Explore PrEP and daily and injectable options. Your goals and exposure route help guide the choice.
Sexual-health care that fits your anatomy and preferences
Tell the clinician the language, pronouns and examination approach that help you feel comfortable. Test selection depends on anatomy and exposure, so discuss genital, oral and anal sites without assuming a standard panel based on gender identity. You may ask what each examination or sample involves and discuss a support person or other available accommodations with the service. PrEP, doxy-PEP and cervical HPV screening have product- and population-specific criteria; respectful care includes explaining those limits clearly. Agree on confidential result communication and follow-up for symptoms or positive results. Availability of a particular accommodation still needs confirmation.
STI testing, panels and treatment follow-up
STI testing works best when the tests match your symptoms, exposure sites and timing. You can request routine screening, evaluation after a partner’s diagnosis or care for symptoms. A broad panel may be useful, but there is no single test that rules out every STI at every body site. A respectful visit should explain what is included, what is omitted and what the next step will be for each result.
How sTI testing, panels and treatment follow-up works
Different tests detect different organisms or the immune response to them. Chlamydia and gonorrhea commonly use NAAT on urine or swabs. HIV and syphilis generally use blood testing. A symptomatic sore may need a lesion swab; cervical HPV screening serves a different purpose from a general STI panel. Results cannot be interpreted simply as ‘clean’ or ‘not clean.’ An infection is a health issue, not a judgment about a person.
Eligibility: STI testing, panels and treatment follow-up
Screening recommendations reflect age, anatomy, pregnancy, sexual practices and previous infections. You do not need symptoms to have an infection. If you have burning, discharge, sores, a rash or pelvic pain, request evaluation as well as tests. Tell the clinician about pregnancy, PrEP/PEP, previous positive results and recent antibiotics. A recent qualifying HIV exposure within 72 hours needs urgent PEP assessment.
What to expect: STI testing, panels and treatment follow-up
Choose targeted tests or a panel
Review the reason for testing. A specific partner diagnosis may need a focused test plus related screening. A panel should have a written list of infections and specimens, not just a reassuring name.
Sample exposed sites
Discuss oral, anal and vaginal contact so throat, rectal or genital samples can be included when appropriate. A urine-only panel cannot rule out infection at unsampled sites.
Plan results and treatment
Ask how results are delivered and which clinician acts on a positive, reactive or invalid result. Some screenings require confirmation. Treatment may be started on clinical grounds in selected situations, but a collection visit alone is not a prescription.
Arrange prevention and follow-up
Discuss partner evaluation, repeat screening, vaccination and HIV prevention. After treatment, test of cure and reinfection screening are different tasks with infection-specific timing.
Preparing for your appointment
Bring exposure dates, previous results, medicines, allergies and pregnancy information. Follow the lab’s specimen instructions. Explain whether private communication is needed and where messages may be sent. Ask whether insurance explanations of benefits or a shared portal could reveal the visit; the service can discuss available communication options without promising absolute secrecy.
Risks and when to seek help
Severe pelvic pain, fever, significant testicular pain, eye or neurologic symptoms, or a rapidly worsening illness needs urgent assessment. An early negative result may not exclude a recent infection. Routine herpes blood screening is not recommended for everyone because of test limitations; symptomatic lesions need a different evaluation. HPV screening is not a universal test for all genders, sites or STI concerns.
Follow-up and treatment review
Review every result, including pending or indeterminate tests, rather than assuming silence means everything is negative. A positive infection needs its treatment and partner plan. Ongoing screening frequency reflects risk and any PrEP/doxy-PEP program. If symptoms persist despite negative tests, return for an examination and consideration of other causes.
Appointments, costs and coverage
When seeking same-day or walk-in care, confirm whether the site can evaluate symptoms, collect all needed specimens and arrange treatment. Visit availability, collection time and result turnaround are separate. Ask for visit, panel, confirmatory test and medication costs separately. Confirm turnaround, insurance terms and an actual appointment for the requested care. Public sexual-health services can be another access route when appropriate.
Questions about your care
Possible HIV exposure within 72 hours?
Possible HIV exposure is time-sensitive. Seek PEP assessment as soon as possible, ideally within 24 hours and no later than 72 hours after a qualifying exposure. PEP is a 28-day course of antiretroviral medication used after exposure; it is different from ongoing PrEP. Do not wait for symptoms, a partner’s results, insurance approval or a routine appointment. If a clinic cannot assess you promptly, go to an emergency department or another service able to start PEP.
Tell the service the exact date and time, what happened, any prior PrEP doses and what is known about the source. If sexual assault occurred, urgent care can also address injuries, pregnancy prevention, other infections and support; PEP decisions should not wait for reporting or paperwork.
A baseline HIV test and renal, hepatic, hepatitis, STI or pregnancy testing may be needed. When PEP is indicated, the first dose should not be delayed waiting for laboratory results that are unavailable immediately.
Confirm where the medication will be dispensed, how the full 28-day supply will be obtained and whom to call for side effects or a missed dose. The regimen is selected for age, pregnancy, organ function and interactions.
CDC recommends early contact around 24 hours to check access and tolerance, with clinical/laboratory follow-up at 4–6 and 12 weeks after exposure. Your clinician specifies the HIV antigen/antibody and nucleic-acid tests and any timing adjustments.
Do I have to know which PrEP I want before the visit?
No. You can ask for an HIV-prevention discussion without choosing a product beforehand. The clinician reviews exposure, HIV status, kidney/HBV history, other medicines and preferences, then compares eligible daily-pill and injection options. A recent qualifying exposure within 72 hours needs urgent PEP assessment rather than waiting to choose routine PrEP.
Can I get every STI test from a blood draw?
STI and STD refer to the same infection/testing concern. Testing depends on symptoms, exposure date, sexual contact sites, pregnancy and prior results; there is no universal panel that excludes every STI. Blood is used for infections such as HIV and syphilis, while chlamydia/gonorrhea testing may need urine or genital, throat and rectal samples. A urine test does not exclude infection at an untested throat or rectal site. Ask which exact tests and specimens are included and whether a specific test is appropriate.
Can I ask for a clinician with LGBTQ+ care experience?
Ask the clinic for a clinician with experience in LGBTQ+ sexual-health concerns and explain the care or privacy needs that matter to you. A general clinic listing does not establish a separate specialist credential. Confirm the appointment type and how results, billing and communications will be handled.
Does a full panel include herpes and HPV?
Not necessarily. Ask for the exact test list. Routine herpes blood testing has limitations, and cervical HPV screening is a separate indication-specific service. A named panel does not mean every infection or site is covered.
Are same-day appointments the same as same-day results?
No. A site may see you and collect samples the same day while laboratory results return later. Confirm which tests are rapid, what confirmation may be needed and who will call you.
Can a negative panel explain persistent symptoms?
It may exclude the infections tested at the sampled sites within the relevant windows, but it does not diagnose every cause. Persistent symptoms need reassessment rather than repeated reassurance from the panel name.
Medical sources
- CDC STI testing
- CDC chlamydial infection guidance
- CDC gonococcal infection treatment guidance
- CDC syphilis guidance
- CDC HIV testing
- CDC herpes testing
- CDC HPV guidance
- CDC PEP clinical guidance
- NYC sexual-health clinics
- CDC clinical guidance for PrEP
- CDC doxycycline PEP recommendations
- CDC 2025 nonoccupational HIV PEP recommendations
- HHS: patient privacy and health information
HIV testing and STI testing. Tell the clinician which sites of exposure are relevant; urine or blood tests alone may not cover every need.
Seek urgent PEP evaluation. PEP must begin within 72 hours when indicated. Do not wait for a routine appointment.
Discuss vaccines, condoms, repeat testing and a plan to receive results. Doxy PEP can reduce certain bacterial STIs for selected patients, but it does not prevent HIV and is not recommended for everyone.
Choose your PrEP care pathway
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Compare PrEP optionsContent was updated September 15, 2026 from the sources cited on the cited resources. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.